These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28704228)

  • 1. Patient attitudes to clozapine initiation.
    Gee SH; Shergill SS; Taylor DM
    Int Clin Psychopharmacol; 2017 Nov; 32(6):337-342. PubMed ID: 28704228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 3. Helping clozapine help: a role for support groups.
    Zita DF; Goethe J
    Schizophr Bull; 2002; 28(1):123-6. PubMed ID: 12047011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device.
    Kelly DL; Ben-Yoav H; Payne GF; Winkler TE; Chocron SE; Kim E; Kitchen C; Stock V; Vyas G; Love RC; Wehring HJ; Sullivan KM; Feldman S; Liu F; McMahon RP; Ghodssi R
    Clin Schizophr Relat Psychoses; 2018; 12(1):23-30. PubMed ID: 26218235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticipatory Clozapine Dosing After Discharge From Inpatient Treatment for the Patient With Comorbid Schizophrenia and Tobacco Use.
    Nguyen AS; Grossman-Kahn R; Wichser L
    J Clin Psychopharmacol; 2020; 40(6):618-619. PubMed ID: 33065717
    [No Abstract]   [Full Text] [Related]  

  • 9. Patients' and relatives' assessment of clozapine treatment.
    Angermeyer MC; Löffler W; Müller P; Schulze B; Priebe S
    Psychol Med; 2001 Apr; 31(3):509-17. PubMed ID: 11305859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone.
    Still DJ; Dorson PG; Crismon ML; Pousson C
    Psychiatr Serv; 1996 Dec; 47(12):1382-4. PubMed ID: 9117479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.
    Tracy DK; Joyce DW; Sarkar SN; Mateos Fernandez MJ; Shergill SS
    BMC Psychiatry; 2015 Jul; 15():174. PubMed ID: 26205327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine action on auditory P3 response in schizophrenia.
    Niznikiewicz MA; Patel JK; McCarley R; Sutton J; Chau DT; Wojcik J; Green AI
    Schizophr Res; 2005 Jul; 76(1):119-21. PubMed ID: 15927806
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
    Grover S; Chakrabarti S; Hazari N; Avasthi A
    Psychiatry Res; 2017 Mar; 249():349-353. PubMed ID: 28152470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clozapine on motor function in schizophrenic patients.
    Vrtunski PB; Konicki PE; Kwon KY; Jurjus G; Jaskiw GE
    Schizophr Res; 1996 May; 20(1-2):187-98. PubMed ID: 8794509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M; Knopf U; Henn FA; Thome J
    Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practitioner attitudes to clozapine initiation.
    Gee S; Vergunst F; Howes O; Taylor D
    Acta Psychiatr Scand; 2014 Jul; 130(1):16-24. PubMed ID: 24004162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.
    Zoccali R; Muscatello MR; Bruno A; Cambria R; Micò U; Spina E; Meduri M
    Schizophr Res; 2007 Jul; 93(1-3):109-16. PubMed ID: 17383857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive loxapine in a clozapine-resistant cohort of schizophrenic patients.
    Mowerman S; Siris SG
    Ann Clin Psychiatry; 1996 Dec; 8(4):193-7. PubMed ID: 8986313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine-associated asterixis: case report.
    Kwak YT; Yang Y; Koo MS
    J Clin Psychopharmacol; 2014 Feb; 34(1):165-7. PubMed ID: 24158019
    [No Abstract]   [Full Text] [Related]  

  • 20. Bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia.
    al-Semaan Y
    Can J Psychiatry; 1996 Sep; 41(7):484-5. PubMed ID: 8884041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.